Riskpilot← Back to searchSign inGet full accessSwesmed Holding AB
ABActiveOrg 5568769417Skjulstagatan 15Activities of head offices · NACE 7010Est. 20110 employees
Revenue 2025
SEK 0
EBITDA margin
—
+37% vs 2024
Equity ratio
57.6%
Financial strength
Net profit 2025
SEK 2K
-98% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -18K | +37% |
| Net profit | SEK 2K | -98% |
| Total assets | SEK 703K | -16% |
| Equity | SEK 405K | +0% |
| Employees | 0 | — |
Legal name
Swesmed Holding AB
Org number
5568769417
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
19 december 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska äga och förvalta aktier i dotterbolag, kapital- förvaltning samt därmed förenlig verksamhet.
Address
Skjulstagatan 15
Email
info@swesmed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −18 | −18 | −19 | −29 | −18 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −18 | −18 | −19 | −29 | −18 |
| Net financials | — | — | — | — | −0 |
| Profit before tax | −18 | 212 | −19 | 101 | 2 |
| Tax | −0 | −0 | −0 | — | — |
| Net profit | −18 | 212 | −19 | 101 | 2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 704 | 703 | 701 | 835 | 703 |
| Equity | 110 | 321 | 302 | 403 | 405 |
| Long-term debt | 226 | 226 | 226 | 226 | 1 |
| Short-term debt | 369 | 156 | 174 | 206 | 298 |
| Total debt | 595 | 382 | 400 | 432 | 298 |
EBITDA margin
-1832100.0%
This company
15.8%
Market median
-11595670% vs market
20212025
Equity ratio
57.6%
This company
38.2%
Market median
+51% vs market
20212025
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20212025
Net profit margin
178400.0%
This company
8.1%
Market median
+2202369% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EE Chief Executive Officer | Chief Executive Officer | 2025 |
SJ Audit | Audit | 2025 |
| Former (2) | ||
BE | Audit | 2024 – 2025 |
RE Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Swesmed Holding AB 
Swesmed ABBoard members of Swesmed Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Erik Eketrä Hallander | Audit | 0 companies |
| Rickard Eric Olsson | Audit | 0 companies |
| Einar Elias Mirhag | Chief Executive Officer | 0 companies |
| Stig Jonas Ekman | Audit | 0 companies |
| Rickard Sven Claes-Olov Ekström | Board of Directors | 0 companies |
| Dan Edvin Mirhag | Deputy Board Member | 0 companies |